MAPT and Alzheimer disease: The severe impact of brain insulin resistance not only on neuronal glucose metabolism (critical for their functionality), but also on the Aβ and tau pathological evolution highlights how “invasive” and relevant T2DM course could be upon cognitive impairment and AD onset.